This report was recently updated on November 17 2024 with the latest and most recent
market numbers
Global Infectious Disease Point of Care (POC) Analyzers Market Size, Trends & Analysis - Forecasts to 2026 By Sample Type (Blood, Nasopharyngeal, Urine, Saliva, Stool, and Vaginal Secretion), By Type of Detection (Bacterial Detection, Fungal Detection, Virus Detection, Antibody Presence, Antigen Presence, Protein Detection, and Others), By Product Type (Benchtop POC Analyzer, and Portable POC Analyzer), By End-User (Hospital Laboratories, Diagnostic Testing Laboratories, Pharma & Biotech Laboratories, Research Institutes, and Others), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
Diseases or disorders caused due to microorganisms such as viruses, bacteria, fungi, and parasites are called infectious diseases. Because these diseases are highly transformable via air, water, or soil, the infection can pass on from person to person. Increasing demand for quick analysis and testing of these microbes is boosting the entire analytical instrumentation industry. Moreover rising pressure on the government and the country’s economy due to the increasing prevalence of deadly and chronic infectious diseases (such as HIV, Tuberculosis (TB), hepatitis, STDs, etc.) along with the outbreak of COVID-19 will support the growth of the industry. Hence, a rising need for portable or point-of-care analytical instruments (benchtop or handheld) will be witnessed during the forecast period. On the contrary, traditional ways to detect pathogens were old microbiology techniques where the sample filled with the unknown microbes was cultured with the following procedure of microbe identification. The other old technique was to draw blood samples from the infected patients for the presence of the antibodies which were developed in response to an unknown infection. Hence, because of the lengthy and time-consuming procedures, the consumer demand shifted to POC or point of care infectious disease analysis.Rapid technological advancements in communications technologies in a portable form and integration of AI and digital computation have enhanced the speed and efficiency of infectious disease testing. With such advancements, the outcome or the data can be then processed and exchanged amongst healthcare workers. Understanding the importance of short turnaround time, the government of most of the developing economies has released funds for the betterment of the laboratory infrastructure. Also with the rising population in the developing regions, the market for infectious disease POC analyzers will also grow owing to the increasing burden of the rising patient population. The top market players offering handheld Abaxis Europe, Delta Electronics, O & D Biotech, Sichuan Xincheng Biological, and Sugentech, Inc. among others.
Based on the type of sample to be processed in a point of care (POC)analyzer, the segment includes blood, nasopharyngeal, urine, saliva, stool, and vaginal secretion. The blood segment will be the fastest growing and largest market segment from 2021 to 2026. Availability of portable tests for blood samples (that yield more information about the infection and its effects on the blood components) is the major driving factor for this segment to grow.
Based on the type of detection the market is studied for segments such as bacterial detection, fungal detection, virus detection, antibody presence, antigen presence, protein detection, and others. The virus detection segment will be the fastest growing segment in the forecast period. The major contribution to this high CAGR value is the outbreak of the COVID-19 infection and its ongoing effect on the patient population. Rising cases of viral infection across the globe will boost this market segment from 2021 to 2026.
The product type in the market for infectious disease analysis isa benchtop POC analyzer and portable point of care (POC)analyzer. The portable POC analyzers will be the fastest growing segment as compared to the benchtop portable POC analyzers. Rapid technological advancements in communications technologies in a portable form and integration of AI and digital computation have enhanced the speed and efficiency of infectious disease testing. With such advancements, the outcome or the data can be then processed and exchanged amongst healthcare workers.
The major consumers of these portable instruments are hospital laboratories, diagnostic testing laboratories, pharma & biotech laboratories, research institutes, and others. The diagnostic testing laboratories will be the dominant segment in the market followed by the hospital laboratories. Increasing sampling activities due to the outbreak of COVID-19 and other infectious diseases, the sample load has doubled at the diagnostic firms. Moreover rising patient registration at the hospital has also caused an increasing demand for laboratory testing at both hospitals and private labs. Hence, the segments are ought to be the dominant ones from 2021 to 2026.
As per the geographical analysis, the market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central South America (Brazil, Argentina, and Rest of Central and South America).The countries such as the US, Canada, and Mexico (North American region) will be the dominant regional sectors as compared to Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central South America (Brazil, Argentina, and Rest of Central and South America). The major reason is the rising popularity and awareness amongst technicians for fast and efficient disease testing. Also, the presence of the top market players in the US makes this region the prominent region in terms of revenue generation from 2021 to 2026. However, the rising burden of infectious disease cases (which includes COVID-19, HIV, and STDs) in the Asian countries will support the market to be the fastest growing segment.
Abaxis Europe, Alere, BioFire Diagnostics, Biogal – Galed Laboratories, Boditech Med Inc., Credo Biomedical Pte Ltd., Delta Electronics, GenMark Diagnostics, Improve Medical, Magnasense Technologies Oy, NanoEntek, O & D Biotech, OSANG Healthcare, Response Biomedical Corporation, Shenzhen Yhlo Biotech Co., Ltd., Sichuan Xincheng Biological, and Sugentech, Inc.among others are the players in the infectious disease point of care (POC) analyzers market.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Infectious Disease Point of Care (POC) Analyzers Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Infectious Disease Point of Care (POC) Analyzers Market
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
